SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Ren Xue Qun))
 

Search: (WFRF:(Ren Xue Qun)) > Coronavirus Disease...

  • Ma, Lin LuZhongnan Hospital of Wuhan University (author)

Coronavirus Disease 2019 Related Clinical Studies : A Cross-Sectional Analysis

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • 2020-09-02
  • Frontiers Media SA,2020

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:956fb641-6cb3-4a22-9c82-6ef4a450054e
  • https://lup.lub.lu.se/record/956fb641-6cb3-4a22-9c82-6ef4a450054eURI
  • https://doi.org/10.3389/fphar.2020.540187DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Objective: The quality and rationality of many recently registered clinical studies related to coronavirus disease 2019 (COVID-19) needs to be assessed. Hence, this study aims to evaluate the current status of COVID-19 related registered clinical trial. Methods: We did an electronic search of COVID-19 related clinical studies registered between December 1, 2019 and February 21, 2020 (updated to May 28, 2020) from the ClinicalTrials.gov, and collected registration information, study details, recruitment status, characteristics of the subjects, and relevant information about the trial implementation process. Results: A total of 1,706 studies were included 10.0% of which (n=171) were from France, 943 (55.3%) used an interventional design, and 600 (35.2%) used an observational design. Most of studies (73.6%) aimed to recruit fewer than 500 people. Interferon was the main prevention program, and antiviral drugs were the main treatment program. Hydroxychloroquine and chloroquine (230/943, 24.4%) were widely studied. Some registered clinical trials are incomplete in content, and 37.4% of the 1,706 studies may have had insufficient sample size. Conclusion: The quality of COVID-19 related studies needs to be improved by strengthening the registration process and improving the quality of clinical study protocols so that these clinical studies can provide high-quality clinical evidence related to COVID-19.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Yin, XuanHubei University of Medicine (author)
  • Li, Bing HuiHenan University (author)
  • Yang, Jia YuZhongnan Hospital of Wuhan University (author)
  • Jin, Ying HuiZhongnan Hospital of Wuhan University (author)
  • Huang, DiZhongnan Hospital of Wuhan University (author)
  • Deng, TongHenan University (author)
  • Wang, Yun YunZhongnan Hospital of Wuhan University (author)
  • Ren, Xue QunHenan University (author)
  • Ji, JianguangLund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,Family Medicine and Clinical Epidemiology,Lund University Research Groups(Swepub:lu)med-jji (author)
  • Zeng, Xian TaoZhongnan Hospital of Wuhan University (author)
  • Zhongnan Hospital of Wuhan UniversityHubei University of Medicine (creator_code:org_t)

Related titles

  • In:Frontiers in Pharmacology: Frontiers Media SA111663-9812

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view